granted
on 04 Oct 2023
Last Applicant/ Owned by
681 Gateway Blvd
South San Francisco
CA
94080
Serial Number
90136125 filed on 25th Aug 2020
Registration Number
N/A
Correspondent Address
Peter J. Willsey
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development for the treatment and prophylaxis of cancer, allergy, infectious disease, and autoimmune disease; Research and development in the field of immunotherapy; Research and development in the field of vaccines; Drug discovery services; Research and development services in the creation of peptide libraries or collections of bioactive peptides; Scientific and technological serviceRead More
Research and development for the treatment and prophylaxis of cancer, allergy, infectious disease, and autoimmune disease; Research and development in the field of immunotherapy; Research and development in the field of vaccines; Drug discovery services; Research and development services in the creation of peptide libraries or collections of bioactive peptides; Scientific and technological services, namely, scientific research, analysis, and testing in the field of preparing and screening peptide libraries; Research and development of biological drug targets for scientific screening purposes; Scientific research; Biological research and analysis
Peptide libraries, namely, collections and variations of peptides for scientific or research use; Biological preparations for use in industry and science
No 90136125
No Service Mark
No 36998/44
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 05th Oct 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 04th Oct 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th Oct 2023 | SOU EXTENSION 5 GRANTED |
| 27th Sep 2023 | SOU TEAS EXTENSION RECEIVED |
| 27th Sep 2023 | SOU EXTENSION 5 FILED |
| 03rd Mar 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 01st Mar 2023 | SOU TEAS EXTENSION RECEIVED |
| 01st Mar 2023 | SOU EXTENSION 4 FILED |
| 01st Mar 2023 | SOU EXTENSION 4 GRANTED |
| 28th Sep 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
